225 related articles for article (PubMed ID: 23301038)
1. Synthesis, antitubercular activity and mechanism of resistance of highly effective thiacetazone analogues.
Coxon GD; Craig D; Corrales RM; Vialla E; Gannoun-Zaki L; Kremer L
PLoS One; 2013; 8(1):e53162. PubMed ID: 23301038
[TBL] [Abstract][Full Text] [Related]
2. A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone.
Grzegorzewicz AE; Korduláková J; Jones V; Born SE; Belardinelli JM; Vaquié A; Gundi VA; Madacki J; Slama N; Laval F; Vaubourgeix J; Crew RM; Gicquel B; Daffé M; Morbidoni HR; Brennan PJ; Quémard A; McNeil MR; Jackson M
J Biol Chem; 2012 Nov; 287(46):38434-41. PubMed ID: 23002234
[TBL] [Abstract][Full Text] [Related]
3. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis.
Alahari A; Alibaud L; Trivelli X; Gupta R; Lamichhane G; Reynolds RC; Bishai WR; Guerardel Y; Kremer L
Mol Microbiol; 2009 Mar; 71(5):1263-77. PubMed ID: 19183278
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the essential FAS II β-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii.
Belardinelli JM; Morbidoni HR
Mol Microbiol; 2012 Nov; 86(3):568-79. PubMed ID: 22994892
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Resistance Associated with the Inhibition of the Dehydration Step of Type II Fatty Acid Synthase in
Grzegorzewicz AE; Gee C; Das S; Liu J; Belardinelli JM; Jones V; McNeil MR; Lee RE; Jackson M
ACS Infect Dis; 2020 Feb; 6(2):195-204. PubMed ID: 31775512
[TBL] [Abstract][Full Text] [Related]
6. Fluorescently labelled thioacetazone for detecting the interaction with
Singh BK; Singha M; Basak S; Biswas R; Das AK; Basak A
Org Biomol Chem; 2022 Feb; 20(7):1444-1452. PubMed ID: 35084426
[TBL] [Abstract][Full Text] [Related]
7. NSC19723, a Thiacetazone-Like Benzaldehyde Thiosemicarbazone Improves the Efficacy of TB Drugs
Singh P; Rawat S; Agrahari AK; Singh M; Chugh S; Gurcha S; Singh A; Abrahams K; Besra GS; Asthana S; Rawat DS; Singh R
Microbiol Spectr; 2022 Dec; 10(6):e0259222. PubMed ID: 36314972
[TBL] [Abstract][Full Text] [Related]
8. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.
Alahari A; Trivelli X; Guérardel Y; Dover LG; Besra GS; Sacchettini JC; Reynolds RC; Coxon GD; Kremer L
PLoS One; 2007 Dec; 2(12):e1343. PubMed ID: 18094751
[TBL] [Abstract][Full Text] [Related]
9. The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone.
Gopal P; Dick T
Int J Antimicrob Agents; 2015 Apr; 45(4):430-3. PubMed ID: 25704063
[TBL] [Abstract][Full Text] [Related]
10. Point mutations within the fatty acid synthase type II dehydratase components HadA or HadC contribute to isoxyl resistance in Mycobacterium tuberculosis.
Gannoun-Zaki L; Alibaud L; Kremer L
Antimicrob Agents Chemother; 2013 Jan; 57(1):629-32. PubMed ID: 23114755
[TBL] [Abstract][Full Text] [Related]
11. Recycling and refurbishing old antitubercular drugs: the encouraging case of inhibitors of mycolic acid biosynthesis.
Belardinelli JM; Morbidoni HR
Expert Rev Anti Infect Ther; 2013 Apr; 11(4):429-40. PubMed ID: 23566152
[TBL] [Abstract][Full Text] [Related]
12. Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384.
Halloum I; Viljoen A; Khanna V; Craig D; Bouchier C; Brosch R; Coxon G; Kremer L
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096157
[TBL] [Abstract][Full Text] [Related]
13. 1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in
Singh V; Grzegorzewicz AE; Fienberg S; Müller R; Khonde LP; Sanz O; Alfonso S; Urones B; Drewes G; Bantscheff M; Ghidelli-Disse S; Ioerger TR; Angala B; Liu J; Lee RE; Sacchettini JC; Krieger IV; Jackson M; Chibale K; Ghorpade SR
ACS Infect Dis; 2022 Nov; 8(11):2315-2326. PubMed ID: 36325756
[TBL] [Abstract][Full Text] [Related]
14. A new dehydratase conferring innate resistance to thiacetazone and intra-amoebal survival of Mycobacterium smegmatis.
Carrère-Kremer S; Blaise M; Singh VK; Alibaud L; Tuaillon E; Halloum I; van de Weerd R; Guérardel Y; Drancourt M; Takiff H; Geurtsen J; Kremer L
Mol Microbiol; 2015 Jun; 96(5):1085-102. PubMed ID: 25754266
[TBL] [Abstract][Full Text] [Related]
15. The changes in mycolic acid structures caused by hadC mutation have a dramatic effect on the virulence of Mycobacterium tuberculosis.
Slama N; Jamet S; Frigui W; Pawlik A; Bottai D; Laval F; Constant P; Lemassu A; Cam K; Daffé M; Brosch R; Eynard N; Quémard A
Mol Microbiol; 2016 Feb; 99(4):794-807. PubMed ID: 26538472
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
Abate G; Koivula T; Hoffner SE
Int J Tuberc Lung Dis; 2002 Oct; 6(10):933-5. PubMed ID: 12365582
[TBL] [Abstract][Full Text] [Related]
17. 1
Korycka-Machała M; Viljoen A; Pawełczyk J; Borówka P; Dziadek B; Gobis K; Brzostek A; Kawka M; Blaise M; Strapagiel D; Kremer L; Dziadek J
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332069
[TBL] [Abstract][Full Text] [Related]
18. A piperidinol-containing molecule is active against
Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
[No Abstract] [Full Text] [Related]
19. Designing quinoline-isoniazid hybrids as potent anti-tubercular agents inhibiting mycolic acid biosynthesis.
Alcaraz M; Sharma B; Roquet-Banères F; Conde C; Cochard T; Biet F; Kumar V; Kremer L
Eur J Med Chem; 2022 Sep; 239():114531. PubMed ID: 35759907
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in
Kim S; Seo H; Mahmud HA; Islam MI; Kim YS; Lyu J; Nam KW; Lee BE; Lee KI; Song HY
J Microbiol Biotechnol; 2017 Nov; 27(11):1932-1941. PubMed ID: 28870005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
